We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.75B
AUM Growth
+$227M
Cap. Flow
+$450M
Cap. Flow %
6.66%
Top 10 Hldgs %
24.03%
Holding
181
New
21
Increased
67
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$76.7M
2
ZYME icon
Zymeworks
ZYME
+$56.8M
3
ENTG icon
Entegris
ENTG
+$55.4M
4
TSM icon
TSMC
TSM
+$52.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$49.2M

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$49.8M
2
W icon
Wayfair
W
+$45.9M
3
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$41.8M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$23.8M
5
CRWD icon
CrowdStrike
CRWD
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.16%
2 Technology 26.2%
3 Industrials 11.22%
4 Consumer Discretionary 7.43%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONTF
151
DELISTED
ON24
ONTF
$654K 0.01%
+13,478
New +$785K
ABCL icon
152
AbCellera Biologics
ABCL
$1.74B
– –
-300,000
Closed -$12.1M
AMWL icon
153
American Well
AMWL
$181M
– –
-5,505
Closed -$2.79M
AMWL icon
154
PUT
American Well
AMWL
$181M
– –
-1,050
Closed -$525K
APPN icon
155
PUT
Appian
APPN
$1.94B
– –
-3,000
Closed -$375K
DNTH icon
156
Dianthus Therapeutics
DNTH
$6.16B
– –
-62,500
Closed -$7.84M
DPZ icon
157
Domino's
DPZ
$11.7B
– –
-3,110
Closed -$1.19M
ECL icon
158
Ecolab
ECL
$78.6B
– –
-230,000
Closed -$49.8M
EDIT icon
159
PUT
Editas Medicine
EDIT
$413M
– –
-583,900
Closed -$38M
EQIX icon
160
Equinix
EQIX
$103B
– –
-2,520
Closed -$1.8M
FATE icon
161
PUT
Fate Therapeutics
FATE
$293M
– –
-18,900
Closed -$1.8M
LKFT
162
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
– –
-112,000
Closed -$11.1M
IMTX icon
163
Immatics
IMTX
$1.26B
– –
-800,000
Closed -$8.63M
IMTXW
164
DELISTED
Immatics N.V. Warrants
IMTXW
– –
-400,000
Closed -$1.15M
ITT icon
165
ITT
ITT
$17.3B
– –
-117,800
Closed -$9.07M
LMND icon
166
PUT
Lemonade
LMND
$3.76B
– –
-17,000
Closed -$935K
MKC icon
167
McCormick & Company Non-Voting
MKC
$13.7B
– –
-128,840
Closed -$12.3M
NTLA icon
168
PUT
Intellia Therapeutics
NTLA
$1.55B
– –
-551,400
Closed -$30.3M
REGN icon
169
Regeneron Pharmaceuticals
REGN
$77.4B
– –
-30,900
Closed -$14.9M
TECX
170
Tectonic Therapeutic
TECX
$538M
– –
-108,776
Closed -$18.2M
DCPH
171
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-243,000
Closed -$13.9M
KNTE
172
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-175,000
Closed -$6.96M
SGEN
173
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-102,500
Closed -$18M
NEWR
174
PUT
DELISTED
New Relic, Inc.
NEWR
– –
-12,000
Closed -$660K
GWPH
175
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-206,000
Closed -$23.8M
4 5 6
7
8

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Eventide Asset Management held 181 positions worth $6.75B, up 3.5% from $6.52B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $450M of net new capital in Q1 2021, opening 21 new positions and adding to 67 existing holdings. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $45.9M trimmed.

  • Eventide Asset Management's largest Q1 2021 buy was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.
  • Eventide Asset Management added most to Entegris in Q1 2021, an estimated $55.4M increase.
  • Eventide Asset Management's biggest Q1 2021 reduction was Wayfair, cutting an estimated $45.9M.
  • Eventide Asset Management fully exited Ecolab in Q1 2021, selling an estimated $49.8M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.75B portfolio in Q1 2021.
  • Eventide Asset Management opened 21 new positions and closed 25 in Q1 2021.
  • Eventide Asset Management's portfolio value rose 3.5% quarter-over-quarter to $6.75B.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.